Novo Nordisk

252
__📊 ****Novo Nordisk A/S (NVO)****__

ISIN: DK0062498333

****What the Company Does****
💉 Develops treatments for diabetes and obesity
🏥 Produces insulin and other chronic disease medicines

****Future Potential****
📈 Growing demand for obesity and diabetes treatments
🧬 Expansion of next-generation drug development

****Future Risks****
⚔️ Competition from Eli Lilly and other pharmaceutical companies
🌍 Regulatory pressure and patent expiration risks

no advice just an idea

Disclaimer

The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.